从“小修小补”到全面进攻，艾迪药业已不满足于在国内抗HIV市场稳步追赶，以及在人源蛋白领域寻求第二增长曲线，而是试图通过加码全球临床研发，将触角延伸至美国等核心海外市场，完成从本土药企到全球玩家的身份跨越。
Фото: Stefanamer / Getty Images，详情可参考纸飞机下载
。PDF资料对此有专业解读
FT Videos & Podcasts，推荐阅读PDF资料获取更多信息
“But then we saw Meta’s head of AI safety use OpenClaw, and it deleted her entire inbox. That’s the head of safety for Meta. So, if she’s having problems, I think we all have to be asking: ‘How do we make sure that these systems are really hardened? How do we make sure that they’re rigorously tested? How do we make sure that we can actually delegate to them in a trusted way?’ And that’s really the hardest problem to face, right?”
Жители Санкт-Петербурга устроили «крысогон»17:52